Date

2018-06-18 20.00 UTC

Objectives

  1. Discuss representation of diagnostic products (to be used as values for susceptibility observables)
  2. Discuss Free(Unbound) and Total substances, remaining questions

Discussion items


Item
Description
Owner
Notes
Action
 
1Welcome & apologies


 

 
2Conflicts of interest
  • None stated
  
3Previous minutes


4Free and Total Substances
  • The current plan is to represent the base substance, the bound and the free substance as three siblings with a "substance X and derivatives" common subsumer.
  • This would support the Observables use cases of allowing querying for substances without regard for "bound-ness", and to distinguish between bound, free, and total.
  • Three patterns for Observables would be:
    • Free X Observable === Observable & component = Free X
    • Bound X Observable === Observable & component = Bound X (or X bound to Y)
    • Total X Observable === Observable & component X (base substance concept)

5Susceptibility
  • Mapping of LOINC component for Susceptibility LOINC terms

  • There will likely be a new "diagnostic product" hierarchy parallel to the medicinal product hierarchy, reusing attributes and patterns from that hierarchy. The priority of this work is currently unknown
    • The new category would need modeling guidance (cf. Clinical Drug (CD) Concept - Pattern 1a, permission needed!). Some of the items that should be considered are as follows (from Farzaneh and Toni):
    • Do we need a new semantic tag?

    • Can the concepts be modelled with a single pattern/template or are there multiple patterns/templates needed?

    • Can we reuse of some of attributes in medicinal product and CDs? Do we need to create new ones?

    • Does the hierarchy require groupers?

    • Do any concepts have strength ranges?

    • If a concept specifies more than one substance, does each substance have an associated strength?

    • See this page for discussion: Diagnostic products

    • Draft editorial guidelines: Editorial Guidelines for Diagnostic Products Used for Susceptibility Testing

  • Daniel Karlsson to update the editorial guidelines for diagnostic products for susceptibility tests and report back at next meeting

6Next meeting
  • Next meeting is on on 2018-08-20
  • As the LOINC project is on hold, we will shift to monthly Observables calls
 
7AOB   

Meeting Files

  File Modified
File testosterone_owl_el.owl 2018-Jul-11 by Daniel Karlsson
File testosterone_owl_dl.owl 2018-Jul-11 by Daniel Karlsson

Recording


More Zoom details

Topic: Observables meeting

Time: this is a recurring meeting Meet anytime

Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/992630241

Or Telephone:
Dial:
+46 (0) 8 4468 2488 (SE Toll)
+61 (0) 2 8015 2088 (AU Toll)
+32 (0) 2 588 4188 (BE Toll)
+1 647 558 0588 (CA Toll)
+56 41 256 0288 (CL Toll)
+420 2 2888 2388 (CZ Toll)
+45 89 88 37 88 (DK Toll)
+372 880 1188 (EE Toll)
+852 5808 6088 (HK Toll)
+353 (0) 1 691 7488 (IE Toll)
+972 (0) 3 978 6688 (IL Toll)
+370 5214 1488 (LT Toll)
+60 3 9212 1727 (MY Toll)
+356 2778 1288 (MT Toll)
+31 (0) 20 241 0288 (NL Toll)
+64 (0) 9 801 1188 (NZ Toll)
+64 (0) 4 831 8959 (NZ Toll)
+47 2396 0588 (NO Toll)
+48 22 307 3488 (PL Toll)
+351 308 804 188 (PT Toll)
+65 3158 7288 (SG Toll)
+421 233 056 888 (SK Toll)
+386 1888 8788 (SI Toll)
+34 91 198 0188 (ES Toll)
+41 (0) 31 528 0988 (CH Toll)
+44 (0) 20 3695 0088 (GB Toll)
+1 408 638 0968 (US Toll)
+1 646 876 9923 (US Toll)
+1 669 900 6833 (US Toll)

Meeting ID: 992 630 241

International numbers available: https://snomed.zoom.us/zoomconference?m=AQWV2VqAIGYWMcMapl9CoYjsaj1TVS7K